Scientists around St. Louis worry their medical research will lose key funding as the National Institutes of Health (NIH) announced changes on how finance grants can be ...
Andrew Spaventa, the Chief Executive Officer of Singular Genomics Systems , Inc. (NASDAQ:OMIC), recently sold 800 shares of the company's common stock, totaling $15,912. The shares were sold at an ...
Through new partnerships with industry leaders, Nvidia aims to help advance practical use cases for AI in healthcare and life ...
Stavros Papadopoulos, founder and CEO of TileDB, spoke with Pharmaceutical Executive about how modern databases are struggling to handle life sciences data, which in turn limits scientific discovery.
Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...
China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...
Singular Genomics Systems, Inc. (market cap: $50.32M), a company specializing in laboratory analytical instruments, has voluntarily amended its proxy statement following two lawsuits alleging ...
Deals, pipeline updates and geopolitical issues drove the conversation at the 2025 JP Morgan Healthcare conference.
Genomics reported a Q4 EPS loss of $(0.40), missing estimates, while revenue declined 10% year over year. Analysts lowered price targets amid profitability concerns.
PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results ...
Fintech visionary and entrepreneur Michael Carbonara, founder of Ibanera, has unveiled RōM, a new USD stablecoin designed specifically for institutions, fintechs, and banks. Already making waves in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results